Global Advanced Visualization Market Is Expected to Reach USD 6.77 Billion by 2028 : Fior Markets
09 févr. 2021 11h10 HE
|
Fior Markets
Newark, NJ, Feb. 09, 2021 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global advanced visualization market is expected to grow from USD 3.07 billion in 2020 to USD 6.77...
$821.7 Million Worldwide Medical Imaging Information Systems Industry to 2027 - Impact of COVID-19 on the Market
20 janv. 2021 05h18 HE
|
Research and Markets
Dublin, Jan. 20, 2021 (GLOBE NEWSWIRE) -- The "Medical Imaging Information Systems - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The...
Outlook on the Positron Emission Tomography Scanners Global Market to 2030 - Featuring Siemens Healthineers, GE Healthcare and ONCOVISION Among Others
05 janv. 2021 07h58 HE
|
Research and Markets
Dublin, Jan. 05, 2021 (GLOBE NEWSWIRE) -- The "Positron Emission Tomography [PET] Scanners Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030" report has been...
Global Nuclear Imaging Devices and Equipment Market Report 2020: Market to Decline at a CAGR of 21.2% Before Recovering in 2023 - Forecast to 2030
22 déc. 2020 04h58 HE
|
Research and Markets
Dublin, Dec. 22, 2020 (GLOBE NEWSWIRE) -- The "Nuclear Imaging Devices and Equipment Global Market Report 2020-30: COVID-19 Impact and Recovery" report has been added to ResearchAndMarkets.com's...
Positron Emission Tomography Market is expected to grow at a CAGR of 5% | Reports And Data
24 juil. 2019 09h49 HE
|
Reports and Data
New York, July 24, 2019 (GLOBE NEWSWIRE) -- This report on the Positron Emission Tomography market is a thorough analysis of the size, share, demand, growth, gross profits, earnings, and revenue of...
Telix Pharmaceuticals Launches illumet™ Microsite (Kit for the Preparation of 68Ga-PSMA)
23 janv. 2019 08h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix Group”, “Company”), a clinical-stage biopharmaceutical company focused on the...
RadioMedix and Curium Announce FDA Fast Track Designation For 64Cu-Dotatate.
09 janv. 2019 01h00 HE
|
RadioMedix Inc.
Houston, TX and St. Louis, MO, Jan. 09, 2019 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that their investigational diagnostic radiopharmaceutical,...
Telix and Cyclotek Enter into Manufacturing Partnership for Kidney Cancer Imaging
14 oct. 2018 18h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of...
Telix and Nihon Medi-Physics to Collaborate on Renal Cancer Imaging for the Japanese Market
15 août 2018 19h00 HE
|
Telix Pharmaceuticals Limited; Nihon Medi-Physics Co., Ltd.
MELBOURNE, Australia and KYOTO, Japan and TOKYO, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company...
Zecotek Opens LFS Crystal Production Facility in Shanghai, China
03 juil. 2018 08h18 HE
|
Zecotek Photonics Inc.
VANCOUVER, British Columbia, July 03, 2018 (GLOBE NEWSWIRE) -- Zecotek Photonics Inc. (“Zecotek” or the “Company”) (TSX-V:ZMS) (Frankfurt:W1I) (OTCPK:ZMSPF), a developer of leading-edge photonics...